ASMB Assembly Biosciences Inc

Assembly Biosciences Inc is a clinical stage biotechnology company advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.

$1.63  -0.02 (-1.21%)
As of 05/23/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/17/2010
Outstanding shares:  48,216,473
Average volume:  367,978
Market cap:   $79,557,180
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BP4WW00
Valuation   (See tab for details)
PE ratio:   -4.18
PB ratio:   0.53
PS ratio:   12.72
Return on equity:   -85.66%
Net income %:   -2,010.65%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy